This expert has over 10 years of experience in risk management and regulatory compliance in the financial services industry, with a focus on identifying compliance issues and implementing solutions to mitigate risk. In his work with the CFPB, he identified millions of dollars in remediation for consumers. Formerly, he worked in consumer protection roles with the Consumer Financial Protection Bureau and the California Department of Financial Institutions, as well as in ...
This highly qualified expert has over 30 years of experience as an insurance regulator and consultant. He earned his BS in commerce from Rider College. He is an accredited insurance examiner and is a member of the Statutory Accounting Working Group and NAIC Financial Analysis Working Group. He was formerly an assistant chief insurance examiner for the financial analysis unit, at the New Jersey Department of Banking and Insurance. Additionally, he was an assistant ...
This highly-qualified expert in arbitration and mediation has over 25 years of experience. She earned her BA in philosophy at College of William and Mary and her JD at the University of Richmond. She is a certified mediator with the Florida Supreme Court and a certified arbitrator with AIDA Reinsurance & Arbitration Society. She is active in her field as a member of the Association of South Florida Mediators and the Chartered Property Casualty Underwriter Society. She ...
This qualified expert received his BA from Valparaiso University and is a licensed OSHA trainer for numerous courses. He has managed various construction safety projects including the installation and modification of industrial equipment valued at over a billion dollars. Formerly, he served as a night safety manager for Gallagher Kaiser at General Motors and as a safety manager for NKC American at Toyota Motor Manufacturing. He currently is the safety manager for a ...
This expert received his BA from Cornell University, and his MD and PhD from Albert Einstein College of Medicine. He completed his residency in Psychiatry at UCLA Neuropsychiatric Institute/Brentwood VA Medical Center. He is also a member of numerous academic societies including American Society of Addiction Medicine, American Academy of Addiction Psychiatry, Society of Biological Psychiatry, College of Problems of Drug Dependence and American Psychiatric Association. ...
This expert is the president of a healthcare government relations and regulatory policy consultancy firm that she founded after an extensive career in healthcare and government. She was the Vice President for Government Relations and Public Policy at Celgene and was the Vice President for Regulatory Policy at GE Healthcare. She served in the administration of President George H.W. Bush as Special Assistant for Legislative and Public Affairs in the Office of the ...
This extremely qualified expert is a certified pharmacist with years of experience in community pharmacy management and regulatory affairs. He received both his BS degree in pharmacy and his MBA degree from the University at Buffalo. He is a member of multiple professional associations, including the American Association of Colleges of Pharmacy, the American Pharmacists Association and the American Society for Pharmacy Law. He has given 100+ lectures statewide in NYS. ...
This expert regularly counsels clients on regulatory, transactional and legislative issues affecting the broadcasting, wireless and wireline industries. He is an active member of the Federal Communications Bar Association, for which he has served on the Executive Board since 2013. He also authors a monthly column in Radio Magazine, is editor of a telecom blog, and speaks regularly on panels, including the National Association of Broadcasters, state broadcast ...
This former New York DMV manager has decades of experience working for the Department of Motor Vehicles. He held positions as a Clerk and Operations Manager in the White Plains and Albany offices in the 1980s and became Office Manager of the New York District Office in 1993. For 12 years, he served as the District Director in charge of operations in the MetroNorth District, and he finished his career in the DMV as the Regional Director in charge of the Metropolitan ...
This FDA regulation expert earned her B.S. in Environmental Chemistry from Purchase College and her M.S. in Environmental Science from the University of Colorado Denver. She began her career with the FDA in 1987 as a Chemist in the Denver Districts Laboratory and then became a Compliance Officer in 1992, specializing primarily in medical device and biologics cases. She later managed a group of eight investigators as a Supervisory Consumer Safety Officer and then became a ...
This expert is currently working through her consulting company, within the Pharmaceutical Industry as a consultant, providing guidance and service for all aspects of Regulatory Affairs for the entire product lifecycle of drugs and biologics from discovery to approval/launch and post-marketing. In addition, providing expertise in business development pertaining to regulatory intelligence and regulatory due diligence.
Her experience includes serving as a member of the ...
A 17-year veteran of the U.S. Food and Drug Administration (FDA), this expert served as the Regulatory Counsel to the Associate Commissioner for Regulatory Affairs, and previously, in scientific, inspectional, compliance and criminal and civil enforcement capacities as an FDA Consumer Safety Officer (CSO), Compliance Officer (CO), a Senior Special Agent (SA) with the Office of Criminal Investigations (OCI) and as an analytical regulatory microbiologist. During his last ...
In early October 2020, drugmakers Pfizer and Regeneron Pharmaceuticals were named in a pair of patent infringement lawsuits, filed in California and New York respectively, claiming the companies used patented technology in the development and testing of COVID-19 vaccines and…
Court: United States District Court for the Southern District of Florida Jurisdiction: Federal Case Name: Remington v. Newbridge Sec. Corp. Citation: 2014 U.S. Dist. LEXIS 15867 In this financial dispute case, a FINRA expert’s testimony is challenged for allegedly lacking…
The woman purchased a bottle of over-the-counter Vitamin E supplements manufactured by the defendant pharmaceutical company. After taking several doses of Vitamin E, the woman experienced nausea, stomach cramps, and violent diarrhea, which led to her sudden death. Upon autopsy,…
This case involves a chemical plant in South Dakota that was shut down for various breaches of environmental regulatory codes. It was discovered that over the course of a year, the chemical plant repeatedly violated air quality standards by improperly storing…
This case involves a hip replacement device MDL. It was alleged that the device manufacturer did not provide proper adverse event reports to the FDA as the data was coming in. An expert in FDA regulations was sought to discuss how…
This case involves a distribution rights dispute between a skincare products company and another member of their LLC. The defendant company had exclusive worldwide distribution rights for certain products supplied by the plaintiff entity. However, under their contract, the plaintiff…
This case is a class action suit that arose from an alleged misrepresentation by the defendant of their high-speed internet and broadband services. It was alleged that the defendants misrepresented crucial information and mislead customers as to what they were…
This case involves a wealthy female banking professional from Connecticut who was charged with filing false tax returns and identity theft. It was alleged that the woman in question bypassed the authentication procedures in the electronic tax return filing process to direct refunds…
This case involves a power plant that was forced to suspend its operations after repeatedly violating environmental regulatory codes. The company was found to be in violation of the legal level of certain cancer-causing air pollutants and agreed to limit the…
This case involves a Food and Drug Administration (FDA) exclusivity dispute surrounding the development of a generic drug. On the same day, 2 pharmaceutical companies submitted abbreviated new drug applications for the same generic drug. An expert in FDA regulations with experience…